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We describe moderate hyperbilirubinemia in a 28-year-old man who suffered from gallstones and splenomegaly, with combined 
disorders of hereditary spherocytosis (HS) and Gilbert’s syndrome (GS). Since it is difficult to diagnose HS in the absence of 
signs of anemia, we evaluated both the genetic mutation in the UGT1A1 gene and abnormalities in the erythrocyte membrane 
protein; the former was heterozygous for a UGT1A1 allele with three mutations and the latter was partially deficient in ankyrin 
expression. This is the first report of the concomitance of HS and GS with three heterozygous mutations [T-3279G, A (TA)7TAA, 
and G211A] in the UGT1A1 gene. (Korean J Hepatol 2010;16:321-324)
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INTRODUCTION
Gilbert’s syndrome (GS) is characterized by unconjugated 
hyperbilirubinemia that occurs in the absence of bilirubinuria, 
overt hemolysis, or liver disease.
1 Decreased conjugation of 
bilirubin, due to diminished activity of the conjugation enzyme 
uridine diphosphate-glucuronosyltranferase (UGT1A1) is associated 
with an increased production of monoconjugated bilirubin.
2 
Hereditary spherocytosis (HS) is a common inherited hemolytic 
anemia; it is heterogeneous in its clinical presentation, 
inheritance, molecular basis, and biochemical phenotype.
3 The 
characteristic features of HS include mild anemia, jaundice, and 
splenomegaly. The clinical severity varies, ranges from asymptomatic 
to severe life-threatening hemolytic anemia.
3 GS concomitant 
with HS is associated with higher bilirubin levels and a 5-fold 
increase in the tendency to develop cholelithiasis.
2 We describe 
moderate hyperbilirubinemia and gallstones in a male patient, 
who was given diagnosis of GS. Further evaluation of inappropriate 
hyperbilirubinemia led to detect a combination of HS with partial 
deficiency in ankyrin expression, and GS with heterozygous for a 
UGT1A1 allele with 3 mutations (T-3279G (UGT1A1 60), A 
(TA)7TAA (UGT1A1 28), and G211A (UGT1A1 6)). These 
combined disorders are the first report in a Korean. We also 
present the various strategies for making these diagnoses and 
review the literature on these concomitant disorders.
CASE REPORT
A 28-year-old man presented with watery diarrhea, abdominal 
discomfort, and fever. He had consumed a large amount of 
smoked, raw salmon the other day. He had been diagnosed with 
GS at the age of 12 years due to a history of intermittent 
unconjugated hyperbilirubinemia with normal liver function and 
underwent laparoscopic cholecystectomy for gallstones 1 year 
ago. The patient denied any family history. His height and weight 
were 179 cm and 69 kg, respectively. His body temperature was 
37.6℃. Clinical examination revealed icteric sclera, mild 
tenderness over the whole abdomen, and hyperactive bowel 
sound. Laboratory tests revealed the following findings; white 
blood cell count, 13,700/uL; hemoglobin, 11.0 g/dL; mean 322  The Korean Journal of Hepatology Vol. 16. No. 3, September 2010
Figure 1. UGT1A1 nucleotide sequences amplified from the 
genomic DNA of the patient. (A) Nucleotide sequences of the 
mutated section of the phenobarbital-responsive enhancer module
of UGT1A1. Arrows show the mutation points. Nucleotide T was 
replaced by G at position 3279 (i.e., T-3279G). The point mutation
was heterozygous for T-3279G. (B) Nucleotide sequences of the 
TATA box in the UGT1A promoter. The mutation was 
heterozygous for seven repeats of TA in the TATA box 
[A(TA)7TAA]. (C) Nucleotide sequence of the mutated section 
of exon 1 of UGT1A1. There was a transition mutation at 
nucleotide 211 in exon 1 of UGT1A1. The substitution of 
adenine for guanine changed the codon from GGA to AGA, 
causing R to replace G at position 71 (i.e., G71R). The mutation 
was heterozygous for G71R. 
Figure 2. Ribbon diagram of the predicted three-dimensional 
structure of UGT1A1. The figure was produced by homology-based
modeling using the SWISS-MODEL and PyMOL molecular 
graphic systems. The short arrow (purple ribbons) indicates 
α -helices, and the long arrow indicates the β -sheet. The dotted 
arrow shows the substitution of arginine (R) for glycine (G) in 
codon 71 in the α -helix structure of the mutated UGT1A1, 
which does not cause a significant change in the tertiary 
structure of UGT1A1.
corpuscular volume (MCV) and mean corpuscular hemoglobin 
concentration (MCHC), 98 fL and 38 g/dL, respectively; 
aspartate aminotransferase, 21 IU/L; alanine aminotransferase, 
20 IU/L; total bilirubin, 6.1 mg/dL; direct bilirubin, 0.8 mg/dL; 
gamma glutamyl transpeptidase, 11 IU/L; alkaline phosphatase, 
54 IU/L. Abdominal computed tomography (CT) scan showed 
moderate splenomegaly and evidence of the previous cholecy-
stectomy.
We analyzed the laboratory and the radiologic findings. The 
highest total bilirubin level recorded was 10.3 mg/dL (9.6 
mg/dL, unconjugated). There were two conflicting findings for 
GS diagnosis: moderate splenomegaly and high values of 
unconjugated hyperbilirubinemia. Moreover, he had previously 
undergone surgery for gallstones. Therefore, we conducted 
further examinations to identify additional causes or other 
disorders. Extensive laboratory tests revealed the followings; 
corrective reticulocyte count, 6.3%; lactate dehydrogenase, 529 
IU/; and haptoblobin, 2 mg/dL. The findings of Coombs’ direct 
and indirect tests were normal. We detected many small, dense 
spherocytes in peripheral blood smear. The osmotic fragility was 
increased (begin: 0.52%, end: 0.44% of NaCl). We suspected GS 
coexisting with underlying chronic hemolysis. We could not 
recognize his hemolytic state because the lowest hemoglobin 
level recorded in the past laboratory findings was 13.3 mg/dL. At 
that time of cholecystectomy, the gallstones observed, i.e., a 
black pigment stone and a cholesterol stone, had a size of 7 and 6 
mm, respectively. To clarify the diagnosis of GS and HS, we 
performed DNA sequencing of the UGT1A1 gene and sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
analysis of the red cell membrane proteins. Amplification of 
exons, the promoter region and enhancer regions (the 
phenobarbital responsive enhancer module, PBREM) of the 
UGT1A1 was performed by the polymerase chain reaction of 
genomic DNA.
4 Amplified DNA fragments were sequenced 
directly.
4 We investigated red cell membrane protein defects of 
the patient using SDS-PAGE.
5 We found that the patient was 
heterozygous for a UGT1A1 allele with three mutations (T-3279G 
(UGT1A1 60), A (TA)7TAA (UGT1A1 28), and G211A (UGT1A1 6)) 
(Fig. 1). The 3-dimensional structure of the UGT1A1 protein was 
predicted by using the SWISS-MODEL (Fig. 2). By using the 
Fairbanks system, we detected the decreased expression of 
ankyrin on SDS-PAGE (Fig. 3). The patient was considered for 
A
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Figure 3. SDS-PAGE gel stained with Coomassie brilliant blue 
and containing nine bands, with partial deficiency of ankyrin 
expression being evident from the Fairbanks system (arrow). 
C, normal control; P, patient. 
splenectomy because of the likelihood of cholelithiasis despite 
the mild form of HS. 
DISCUSSION
The UGT1 gene is located on chromosome 2q37. It encodes 9 
functional proteins (UGT1A1, UGT1A3-10). The UGT1A locus 
includes ‘first’ exons and their associated promoters, which are 
spliced separately to four common exons (exons 2-5).
6,7 Of the 
various UGTs characterized to date, particular attention has been 
paid to UGT1A1. Notably, this enzyme is solely responsible for 
bilirubin glucuronidation. Numerous mutations of UGT1A1 that 
influence bilirubin glucuronidation have been identified. Many 
of these have been linked to syndromes, particularly GS and the 
Crigler-Najjar syndromes type I and II.
6 The incidence of GS is 
approximately 3∼10% in the West and 3% in the East.
8 GS 
arises usually due to polymorphism in a TA-repeat element, A 
(TA)5-8TAA, of the UGT1A1 promoter. Maruo et al.
9 reported 
linkage of GS to A (TA)7TAA (UGT1A1 28) and T-3279G 
(UGT1A1 60). An in vitro expression study has revealed that the 
A (TA)7TAA transcription activity is one-third of the normal 
value, and that T-3279G reduces the transcriptional activity to 
60% of the normal value.
9 In addition, mutations in the coding 
region that result in reduced bilirubin-glucuronidation activity 
are also known to be associated with GS in an Asian population. 
The most prevalent mutation (13~23%) is G211A (UGT1A1 6), 
which results in the substitution of glycine for arginine at 
position 71 (G71R) of the UGT1A1 protein.
6,10 An in vitro 
activity study showed that the G71R mutation reduced the total 
bilirubin glucuronidation activity by 50% as compared to its 
normal value.
6
HS is a common inherited disorder that is characterized by 
anemia, jaundice, and splenomegaly. Although the clinical 
symptoms are variable, most patients presented with well- 
compensated hemolytic anemia. The primary lesion in HS is the 
loss of membrane surface area, leading to reduced deformability 
due to defects in the membrane proteins ankyrin, band 3, α 
spectrin, β spectrin, or protein 4.2.
11 Spherocytic red cells, 
precociously trapped in the spleen, are phagocytosed by splenic 
macrophages which results in chronic hemolysis.
12 Common 
complications are cholelithiasis, hemolytic episodes, and aplastic 
crisis. Removal of the spleen results in an increased red cell life 
span, decreased transfusion requirement, and a decreased incidence 
of gallstones. Splenectomy is thus the treatment of choice for 
moderate-to-severe forms of the disease.
11,12
In our case, HS concealed by GS was revealed because the 
patient suffered from food poisoning. Further evaluation showed 
that the patient was heterozygous for triple different mutations in 
the UGT1A1 gene. In addition, the expression of the ankyrin 
protein was decreased in his erythrocyte membrane proteins. The 
unusually high levels of bilirubin observed in our case as 
compared to that reported for GS suggested the coexistence of an 
other disorder. However, the presence of two simultaneous 
causes of unconjugated hyperbilirubinemia may hamper the 
diagnosis. Sharma et al.
13 reported a similar case of HS combined 
with GS.
GS is an heritable risk factor for gallstone formation resulting 
from impaired hepatic bilirubin clearance.
14 Moreover, GS 
concomitant with HS has been associated with higher levels of 
bilirubin and a 5-fold increase in the tendency to develop 
cholelithiasis.
2 Bile salts, calcium, or other biliary components 
could initiate the formation of pigment and cholesterol 
gallstones.
2 Our case suffered from cholecystitis with a black 
pigment stone and a cholesterol stone and had cholecystectomy, 
however, the potential risk of cholelithiasis remained because of 
the chronic hemolysis. Therefore, we made a plan of splenectomy. 
However, it must be emphasized that splenectomy involves a 
surgical risk as well as the risk postsplenectomy sepsis and 
atherosclerotic events.
10 It is not certain what extent the 
unconjugated hyperbilirubin level accounts for HS.
α-spectrin
β-spectrin
Ankyrin
Band 3
Protein 4.1
Protein 4.2
Actin
Protein 6
Protein 7
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Two linked polymorphic mutations (A (TA)7TAA and 
T-3279G)
9 and (A (TA)7TAA and G211A)
10 of UGT1A1 were 
previously reported as the cause of GS. We performed 
amplification by polymerase chain reaction of genomic DNA 
and sequencing directly of promoter region, enhancer region 
exons of UGT1A1. To our knowledge, this is the first report of the 
concomitance of HS and 3 polymorphic, heterozygous mutations 
in the UGT1A1 gene. Thus our patient had three linked 
heterozygous polymorphism, A (TA)7TAA a TA insertion 
mutation in TATA box of the promoter region, T-3279G, located 
in the phenobarbital responsive enhancer module (PBREM), and 
G71R in exon 1. We present the 3-dimensional structure of the 
UGT1A1 protein that was predicted by using the SWISS-MODEL 
according to Li and Wu.
15 It shows the substitution of glycine for 
arginine at position 71 (G71R) of the UGT1A1 protein. 
We used SDS-PAGE for the analysis of erythrocyte membrane 
protein abnormalities. In addition, we also detected the partial 
deficiency of ankyrin. Lee et al.
3 reported that ankyrin deficiency 
was the most common erythrocyte membrane protein defect in 
Korean HS patients.
We report an interesting case of HS with partial deficiency of 
ankyrin expression and GS with mutations in promoter, 
enhancer, and one exon of the UGT1A1 gene. Further evaluation 
is needed to determine the prognosis, and the therapeutic and 
genetic implications.
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